---
title: "Varex Imaging (VREX) Receives a Buy from Oppenheimer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285728897.md"
description: "Oppenheimer analyst Suraj Kalia has maintained a Buy rating on Varex Imaging (VREX) with a price target of $18.00. Kalia, who focuses on the Healthcare sector, has an average return of 6.5% and a 49.49% success rate on his stock recommendations. The overall analyst consensus for Varex Imaging is a Moderate Buy, also with an average price target of $18.00."
datetime: "2026-05-08T12:55:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285728897.md)
  - [en](https://longbridge.com/en/news/285728897.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285728897.md)
---

# Varex Imaging (VREX) Receives a Buy from Oppenheimer

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Varex Imaging, with a price target of $18.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Kalia covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Artivion, and Insulet. According to TipRanks, Kalia has an average return of 6.5% and a 49.49% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Varex Imaging with a $18.00 average price target.

### Related Stocks

- [VREX.US](https://longbridge.com/en/quote/VREX.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)
- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)

## Related News & Research

- [Varex Imaging Q2 adjusted EPS falls](https://longbridge.com/en/news/285619549.md)
- [Universal Beteiligungs und Servicegesellschaft mbH Takes $1.25 Million Position in Varex Imaging $VREX](https://longbridge.com/en/news/284994888.md)
- [Prestige Consumer Healthcare: Buy Rating Reaffirmed Despite Soft Outlook, with Acquisitions and Undervalued Earnings Power Seen as Upside Drivers](https://longbridge.com/en/news/286324184.md)
- [Canaccord Genuity Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)](https://longbridge.com/en/news/286251663.md)
- [Veradermics, Incorporated (MANE) Receives a Buy from Jefferies](https://longbridge.com/en/news/286447750.md)